1992 Fiscal Year Final Research Report Summary
Study on pathology hemorrhagic gastric ulcer and treatments by means of high-technological modalities, with special reference to short and long term prognosis i n the high-age group
| Project/Area Number |
02670587
|
|---|
| Research Category |
Grant-in-Aid for General Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Digestive surgery
|
|---|
| Research Institution | Kitasato Univ |
|---|
Principal Investigator |
HIKI Yoshiki Kitasato University School of Medicine, Professor, 医学部, 教授 (10050395)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
SAIGENJI Katsunori 北里大学, 医学部, 教授 (70050581)
TSUKAMOTO Hideto 北里大学, 医学部, 講師 (60146420)
SHIMAO Hitoshi 北里大学, 医学部, 講師 (00146408)
MIENO Hiroyoshi 北里大学, 医学部, 講師 (80118843)
SAKAKIBARA Yuzuru 北里大学, 医学部, 助教授 (00050451)
|
|---|
| Project Period (FY) |
1990 – 1992
|
| Keywords | Hemorrhagic gastric cancer / Hish-technological modalities / Short-term prognosis / Long-term prognosis / High-age group / Mortality rate / Conservative treatment / Surgical death |
|---|
| Research Abstract |
Our present study was conducted by co-operation between Department of International medicine and Surgery of our hospital, which was highly significant because the results were comprehensive without a bias toward either department.
The present report describes whether or not emergency operations have decreased because of progress in various high technological endoscopic hemostatic method for hemorrhagic ulcer and short-term and long-term prognosis after conservative therapy.
As for the results of conservative treatment, the rate of short-term prognostic hemostasis was 81.3%.
Of the long-term prognostic cases, ulcers recurred in 50%, accompanied by recurrent bleeding in 34.8%.
These patients were again treated by conservative therapy, and hemostasis was successful.
The mortality rate following conservative therapy was 13.7% in the first period and 11.0% in the later period.
The surgical mortality rate was 6.0% in the first period and 5.4% in the later period.
There was no surgical death among the patients under going palliative operation. Our therapeutic policy for hemorrhagic ulcer will be described based on these findings.
|
